Showing results (861-870 of 1,962) with videos related to
Sort By:
Pageof 197
Expert Opinion on Drug Discovery|June 2, 2012
Experimental models for anxiolytic drug discovery in the era of omes and omicsAdam Stewart, Siddharth Gaikwad, Peter Hart, et al.Expert Opinion on Drug Discovery|June 2, 2012
Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptorsWayne Stallaert, Arthur Christopoulos, Michel BouvierExpert Opinion on Drug Discovery|June 2, 2012
Developments in the discovery of drugs for spinal muscular atrophy: successful beginnings and future prospectsRebecca M PrussExpert Opinion on Drug Discovery|June 5, 2012
The application of human tissue for drug discovery and developmentMargaret ClotworthyExpert Opinion on Drug Discovery|June 12, 2012
Increasing the success rate of lantibiotic drug discovery by Synthetic BiologyManuel Montalbán-López, Liang Zhou, Andrius Buivydas, et al.Expert Opinion on Drug Discovery|May 4, 2018
The preclinical discovery and development of cariprazine for the treatment of schizophreniaAnna Wesołowska, Anna Partyka, Magdalena Jastrzębska-Więsek, et al.Expert Opinion on Drug Discovery|June 10, 2017
Current mathematical models for cancer drug discoveryLetizia Carrara, Silvia Maria Lavezzi, Elisa Borella, et al.Expert Opinion on Drug Discovery|August 14, 2018
Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug designXin-Yu Zhang, Adnan A ElfarraExpert Opinion on Drug Discovery|August 7, 2018
Developments in lncRNA drug discovery: where are we heading?Ilya Blokhin, Olga Khorkova, Jane Hsiao, et al.Expert Opinion on Drug Discovery|September 15, 2016
Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinicAngelo B A Laranjeira, Sherry X YangPageof 197